ConductScience.org, home

Gene · 715

Papers2,917

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,917

Download this page as JSON
TitleJournalYearPMIDFound bySource
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.Sci Rep202539753879PubTator, text miningPubMed
Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone.Schizophr Res202539616737PubTator, text miningPubMed
Correspondence to editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease".Clin Mol Hepatol202539253743PubTator, text miningPubMed
A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease".
Clin Mol Hepatol202539188228PubTator, text miningPubMed
Region-Specific Transcriptional Signatures of Brain Aging in the Absence of Neuropathology at the Single-cell Level.bioRxiv202537577533PubTator, text miningPubMed
The assessment of the relationship between the development of cardiovascular diseases and SCUBE-1 level in individuals exposed to loud noise.Medicine (Baltimore)202439705419PubTator, text miningPubMed
Genetic insights into the effect of trace elements on cardiovascular diseases: multi-omics Mendelian randomization combined with linkage disequilibrium score regression analysis.Front Immunol202439691718PubTator, text miningPubMed
Characterising a Novel Therapeutic Target for Psoriasis, TYK2, Using Functional Genomics.Int J Mol Sci202439684939PubTator, text miningPubMed
[Study on serum proteomic characteristics of workers with rare earth samarium oxide pneumoconiosis].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi202439604234PubTator, text miningPubMed
Maternal Serum SCUBE-1: A Novel Ischemic Marker in Preeclampsia.J Pers Med202439590594PubTator, text miningPubMed
STAVER: a standardized benchmark dataset-based algorithm for effective variation reduction in large-scale DIA-MS data.Brief Bioinform202439504480PubTator, text miningPubMed
Identification of Plasma Protein Biomarkers for Predicting Lung Cancer.Anticancer Res202439477293PubTator, text miningPubMed
The dynamics and behavior of logarithmic type fuzzy difference equation of order two.PLoS One202439423196PubTator, text miningPubMed
Protein biomarkers in assessing kidney quality before transplantation‑current status and future perspectives (Review).Int J Mol Med202439370783PubTator, text miningPubMed
Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS-mutant Cancers.Adv Sci (Weinh)202439254172PubTator, text miningPubMed
Generation of rabbit single-chain variable fragments with different physicochemical and biological properties by complementary determining region-grafting technology.J Biosci Bioeng202439198103PubTator, text miningPubMed
Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF-1α-regulated glycolysis.Mol Carcinog202439150096PubTator, text miningPubMed
The Establishment of Complement System Is from Gene Duplication and Domain Shuffling.Int J Mol Sci202439125697PubTator, text miningPubMed
Causal relationship between complement C1QB and colorectal cancer: a drug target Mendelian randomization study.Front Genet202439109334PubTator, text miningPubMed
A novel missense variant in CAT gene causing acatalasemia with gangrenous periodontitis (Takahara's disease).Arch Oral Biol202439079473PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/715/papers?page=5